Literature DB >> 26269223

Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?

Aman Sharma1, Ritambra Nada2, Godasi S R S N K Naidu3, Ranjana W Minz4, Harbir Singh Kohli3, Vinay Sakhuja3, Krishan Lal Gupta3, Manish Rathi3.   

Abstract

AIM: A significant proportion of pauci-immune glomerulonephritis (PIGN) patients are reported to have absence of anti-neutrophilic cytoplasmic antibodies (ANCA). However, studies are controversial regarding their significance and there is limited data after the new prognostic classification of PIGN.
METHODS: Renal biopsy-proven cases of PIGN were included and their clinical details, ANCA status by immunofluorescence (IIF) and enzyme-linked immunosorbent assay (ELISA), Birmingham Vasculitis Activity Score (BVAS) and treatment outcomes at 6 months were noted. The renal biopsies were classified according to the proposed histopathological classification. Scoring was done from 0-3 for interstitial edema, interstitial fibrosis and tubular atrophy (IFTA), interstitial inflammation and arteriosclerosis. The percentage of glomeruli with sclerosis, cellular and fibrous crescents, and percentage of subjects with glomerulitis, tuft necrosis, interstitial granuloma and vasculitis were noted.
RESULTS: Out of the 84 subjects included in the study, 33 (39.3%) were negative for ANCA by both IIF and ELISA. These subjects had significantly higher renal involvement, less extra-renal manifestations and lower BVAS. On histology, they had significantly higher proportion of crescentic class (66.7% vs. 41.2%, P = 0.039), higher number of cellular crescents (66.12% vs. 53.3%, P = 0.00008), higher IFTA (1.53 vs. 1.02, P = 0.009) and less interstitial edema (1.44 vs. 1.96, P = 0.003). The treatment outcomes were worse in ANCA-negative PIGN subjects, with significantly less improvement (37.2% vs. 62.8%, P = 0.02), more deterioration (40.7% vs. 14%, P = 0.006), and reduced probability of becoming dialysis free (31.6% vs. 69.6% P = 0.009).
CONCLUSIONS: A negative ANCA in PIGN is associated with crescentic class, more IFTA and poor treatment outcomes.
© 2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  anti-neutrophilic cytoplasmic antibodies; pauci-immune glomerulonephritis; rapidly progressive glomerulonephritis; renal biopsy

Mesh:

Substances:

Year:  2015        PMID: 26269223     DOI: 10.1111/1756-185X.12729

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  5 in total

1.  Unique case of ANCA-negative pauci-immune necrotizing glomerulonephritis with diffuse alveolar hemorrhage, potentially associated with midostaurin.

Authors:  Jonathan D Pankow; Guillaume Richard-Carpentier; Naval G Daver; William F Glass; Jaya Kala
Journal:  CEN Case Rep       Date:  2020-01-18

Review 2.  Narrative Review of Hypercoagulability in Small-Vessel Vasculitis.

Authors:  Sophie E Claudel; Bryan M Tucker; Daniel T Kleven; James L Pirkle; Mariana Murea
Journal:  Kidney Int Rep       Date:  2020-01-13

3.  Methimazole-Induced Pauci-Immune Glomerulonephritis and Anti-Phospholipid Syndrome: An Important Association to Be Aware of.

Authors:  Huzaif Qaisar; Mohammad A Hossain; Monika Akula; Jennifer Cheng; Mayurkumar Patel; Zheng Min; Halyna Kuzyshyn; Michael Levitt; Shana M Coley; Arif Asif
Journal:  J Clin Med Res       Date:  2018-09-10

4.  Significance of Crescentic Glomeruli in Acute Kidney Injury with Rheumatoid Arthritis.

Authors:  Ali Ayaash; Dipesh Maan; Anastasios Kapetanos; Mark Bunker; Mary Chester Wasko; Barbara Clark
Journal:  Case Rep Nephrol Dial       Date:  2019-04-30

5.  Histopathological Classification-A Prognostic Tool for Rapidly Progressive Glomerulonephritis.

Authors:  Marta Kantauskaitė; Agnė Laučytė-Cibulskienė; Marius Miglinas
Journal:  Medicina (Kaunas)       Date:  2018-04-17       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.